Patents for A61P 19 - Drugs for skeletal disorders (81,981)
01/2011
01/19/2011EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
01/19/2011EP1448995B1 Assay for screening candidate drugs for the treatment of inflammatory diseases
01/19/2011EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
01/19/2011EP1185296B1 Prevention and treatment of amyloidogenic diseases
01/19/2011CN201710673U Cold compress pain relieving paste
01/19/2011CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
01/19/2011CN1857385B Medicine composition for treating cervical spondylosis and its preparing method
01/19/2011CN101952313A 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
01/19/2011CN101952283A Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives
01/19/2011CN101951919A Combined use of 25-hydroxy-vitamin D3 and vitamin D3 for improving bone mineral density and for treating osteoporosis
01/19/2011CN101951915A Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and WNT signaling
01/19/2011CN101951903A Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
01/19/2011CN101948539A IL-18 binding proteins
01/19/2011CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof
01/19/2011CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity
01/19/2011CN101948430A Sinomenine derivative and preparation method and applications thereof
01/19/2011CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same
01/19/2011CN101947352A Neck rehabilitation cushion for preventing, treating and adjusting cervical vertebra disequilibrium
01/19/2011CN101947306A Treatment of T-cell mediated diseases
01/19/2011CN101947291A Chinese medicinal composition for treating osteoproliferation and herniated disk and preparation method thereof
01/19/2011CN101947279A Traditional Chinese medicine for treating hyperosteogeny
01/19/2011CN101947277A Chinese medicinal oral preparation for treating rheumatism, rheumatoid diseases and arthritis
01/19/2011CN101947276A Chinese medicinal composition for treating rheumatic arthritis
01/19/2011CN101947251A Method for preparing chickpea isoflavone microcapsules
01/19/2011CN101947234A Preparation method for preparation containing glucosamine and application thereof
01/19/2011CN101947230A Application of 5'-AMP for treating urarthritis
01/19/2011CN101947215A Application of flavonoid compound in tangerine peel to preparation of medicament for inhibiting angiogenesis
01/19/2011CN101947155A Electric hot water bag with Chinese herbal medicine solution for treating arthritis and functions of massage and temperature control
01/19/2011CN101946986A Nanometer anion fabric seaman body-building working uniform with characteristics of ultra-oleophobic and ultra-hydrophilic properties, antifouling property and self-cleaning property
01/19/2011CN101627986B Acedofenac-paracetamol pharmaceutical composite and liposome solid preparation thereof
01/19/2011CN101564462B Chinese medicament for treating diabetic osteoporosis
01/19/2011CN101548969B Use of ethyl malonyl silybin derivant in preparing antioxidant medicine
01/19/2011CN101450184B Plaster for treating rheumatism bone disease
01/19/2011CN101391064B Composition for treating lumbar intervertebral disc protrusion
01/19/2011CN101366891B Medicine pillow for preventing and controlling cervical spondylosis and preparation method thereof
01/19/2011CN101362731B Heterocyclic compounds and methods of use
01/19/2011CN101327223B Medicament for treating osteonecrosis and cytoskeleton thereof
01/19/2011CN101264275B Medicated pillow for treating scapulohumeral periarthritis and cervical spondylosis
01/19/2011CN101254286B Chinese medicinal composition for curing wind dampness and rheumatoid
01/19/2011CN101249237B Chinese medicine bone fracture plaster and method of preparing the same
01/19/2011CN101249179B Medicine for external application for curing hyperosteogeny and disc herniation and method of preparing the same
01/19/2011CN101237885B Agent for regeneration and/or protection of nerves
01/19/2011CN101190277B Method for preparing stemmacantha uniflora blood circulation-activating, stasis-removing and wind-damp-expelling wine
01/19/2011CN101167818B Hyperosteogeny plaster
01/19/2011CN101119716B External plaster containing flurbiprofen
01/19/2011CN101014578B Triazole derivative or salt thereof
01/19/2011CN101002848B Medicine for treating recurrent uarthritis, and its preparing method
01/18/2011US7872151 Inhibitors of α4 mediated cell adhesion
01/18/2011US7872142 Coumarin derivatives useful as TNFα inhibitors
01/18/2011US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma
01/18/2011US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent
01/18/2011US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer
01/18/2011US7872098 derivatives of peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY pharmaceutical compositions; capable of stimulating in vitro the proliferation and the secretion of IL-2 by the CD4+ T cells purified from the ganglia
01/18/2011US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
01/18/2011US7871992 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
01/18/2011US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis
01/18/2011US7871644 Mixture of drug, aminoacrylate polymer and acid
01/18/2011CA2566160C Pyrrolopyrimidine derivatives useful in cancer treatment
01/18/2011CA2500225C Pyrazole compounds
01/18/2011CA2475630C N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
01/18/2011CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient
01/18/2011CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
01/18/2011CA2418977C Gene delivery vectors with cell type specificity for primary human chondrocytes
01/18/2011CA2331460C Heterocyclic inhibitors of p38
01/18/2011CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
01/13/2011WO2011005853A2 Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome
01/13/2011WO2011005832A1 Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl] -benzoylamino} -4-methylenξ-penta nedioic acid
01/13/2011WO2011005574A2 Compositions and methods for regulating chondrocyte proliferation in bone disorders
01/13/2011WO2011005290A1 Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders
01/13/2011WO2011004847A1 NOVEL HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY
01/13/2011WO2011004734A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor
01/13/2011WO2011004733A1 Activity enhancer for oxidized protein hydrolase
01/13/2011US20110009955 Compounds and method for coating surfaces in a hemocompatible manner
01/13/2011US20110009625 Novel compounds
01/13/2011US20110009491 Process for producing 1,4-dihydroxy-2-naphthoic acid
01/13/2011US20110009474 Sirtuin based methods and compositions for treating beta-catenin-related conditions
01/13/2011US20110009467 Methods to Increase or Decrease Bone Density
01/13/2011US20110009463 Geranylgeranyl transferase inhibitors and methods of making and using the same
01/13/2011US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity
01/13/2011US20110009450 Crystalline form of benzothiophene compound and process for preparation thereof
01/13/2011US20110009449 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
01/13/2011US20110009448 Compound
01/13/2011US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis
01/13/2011US20110009439 Indene derivatives as pharmaceutical agents
01/13/2011US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
01/13/2011US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof
01/13/2011US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof
01/13/2011US20110009428 Novel androgens
01/13/2011US20110009396 Tricyclic compounds for the treatment of inflammatory disorders
01/13/2011US20110009385 Compounds
01/13/2011US20110009328 Polypeptide Derivatives of Parathyroid Hormone (PTH)
01/13/2011US20110009327 Bioactive nanocomposite material
01/13/2011US20110009321 Nasal calcitonin formulations containing chlorobutanol
01/13/2011US20110009316 Proteolysis resistant active vegf
01/13/2011US20110009312 Albumin Fusion Proteins
01/13/2011US20110008460 Biomimetic hydroxyapatite composite materials and methods for the preparation thereof
01/13/2011US20110008432 Method for Treating a Patient in Need of Aspirin Therapy
01/13/2011US20110008374 Use of IL-1 Antagonists to Treat Gout
01/13/2011US20110008366 Inhibition of versican with sirna and other molecules
01/13/2011US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity